IN2014DN05281A - - Google Patents

Info

Publication number
IN2014DN05281A
IN2014DN05281A IN5281DEN2014A IN2014DN05281A IN 2014DN05281 A IN2014DN05281 A IN 2014DN05281A IN 5281DEN2014 A IN5281DEN2014 A IN 5281DEN2014A IN 2014DN05281 A IN2014DN05281 A IN 2014DN05281A
Authority
IN
India
Prior art keywords
compound
reacted
pyrazolo
fluorobenzyl
pyridin
Prior art date
Application number
Other languages
English (en)
Inventor
Jin Li
Xiaoyu Yang
Jingwei Zhu
Minmin Yang
Xihan Wu
Original Assignee
Pharmablock Nanjing R & D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmablock Nanjing R & D Co Ltd filed Critical Pharmablock Nanjing R & D Co Ltd
Publication of IN2014DN05281A publication Critical patent/IN2014DN05281A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN5281DEN2014 2011-12-12 2012-11-28 IN2014DN05281A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110414004.0A CN102491974B (zh) 2011-12-12 2011-12-12 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法
PCT/CN2012/085451 WO2013086935A1 (zh) 2011-12-12 2012-11-28 1-(2-氟苄基)-1H -吡唑并[3,4- b]吡啶-3 -甲脒盐酸盐的合成方法

Publications (1)

Publication Number Publication Date
IN2014DN05281A true IN2014DN05281A (enExample) 2015-04-03

Family

ID=46183843

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5281DEN2014 IN2014DN05281A (enExample) 2011-12-12 2012-11-28

Country Status (7)

Country Link
US (1) US8957210B2 (enExample)
JP (1) JP5791825B2 (enExample)
CN (1) CN102491974B (enExample)
DE (1) DE112012005176B4 (enExample)
IL (1) IL233066B (enExample)
IN (1) IN2014DN05281A (enExample)
WO (1) WO2013086935A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102491974B (zh) 2011-12-12 2013-08-07 南京药石药物研发有限公司 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法
CN104086545A (zh) * 2014-07-29 2014-10-08 安徽联创药物化学有限公司 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法
CN105237531A (zh) * 2015-10-15 2016-01-13 湖南华腾制药有限公司 一种利奥西呱中间体的制备方法及其中间体化合物
CA3006764A1 (en) 2015-12-14 2017-06-22 Ironwood Pharmaceuticals, Inc. Use of sgc stimulators for the treatment of gastrointestinal sphincter dysfunction
EP3554488A2 (en) 2016-12-13 2019-10-23 Cyclerion Therapeutics, Inc. Use of sgc stimulators for the treatment of esophageal motility disorders
SG11202100092QA (en) 2018-07-11 2021-02-25 Cyclerion Therapeutics Inc USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONRIAL DISORDERS
CN115947689B (zh) * 2022-09-23 2025-08-29 湖南华腾制药有限公司 一种连续流微反应器合成利奥西呱中间体的方法
CN117024334A (zh) * 2023-07-20 2023-11-10 重庆医药高等专科学校 一种2-氟-3-羟基吡啶的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031176A1 (es) * 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10220570A1 (de) * 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
CL2009000448A1 (es) * 2008-02-29 2009-11-27 Genentech Inc Compuestos derivados de 3-sulfonilamino-n-(1h-pirazolo-[3,4-b]piridin-5il)benzamida; procesos de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento del cancer, tal como sarcoma, carcinoma, adenoma, entre otros.
EP2352501B1 (en) * 2008-11-03 2014-01-01 ChemoCentryx, Inc. Compounds for use in the treatment of osteoporosis
CN101648909B (zh) * 2009-09-14 2011-10-05 南京第一农药集团有限公司 一种氯代吡啶在无配体钯催化下制备氰基吡啶的方法
US20110225969A1 (en) * 2010-03-19 2011-09-22 Gm Global Technology Operations, Inc. Compressor bypass to exhaust for particulate trap regeneration
DE102010021637A1 (de) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
AU2011257336B2 (en) * 2010-05-26 2015-11-19 Adverio Pharma Gmbh The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
EP2575473B1 (en) * 2010-05-27 2016-01-20 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
RS54526B1 (sr) * 2011-04-22 2016-06-30 Pfizer Inc. Upotreba derivata pirazolospiroketona kao inhibitora acetil-coa karboksilaze
MX348470B (es) * 2011-09-02 2017-06-13 Bayer Ip Gmbh Pirimidinas anilladas sustituidas y uso de las mismas.
CN102491974B (zh) 2011-12-12 2013-08-07 南京药石药物研发有限公司 1-(2-氟苄基)-1H-吡唑并[3,4-b]吡啶-3-甲脒盐酸盐的合成方法

Also Published As

Publication number Publication date
JP2015500248A (ja) 2015-01-05
DE112012005176T5 (de) 2014-08-28
IL233066A0 (en) 2014-07-31
CN102491974A (zh) 2012-06-13
IL233066B (en) 2019-01-31
WO2013086935A1 (zh) 2013-06-20
DE112012005176B4 (de) 2018-10-11
JP5791825B2 (ja) 2015-10-07
US20140309425A1 (en) 2014-10-16
CN102491974B (zh) 2013-08-07
US8957210B2 (en) 2015-02-17

Similar Documents

Publication Publication Date Title
IN2014DN05281A (enExample)
IL196894A (en) A process for making 3-dihalomethylpyrazole 4-carboxylic acid
NZ603268A (en) Process for synthesizing oxidized lactam compounds
EP4023641A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
MX2009008662A (es) Metodo para la produccion de 2,3,3,3-tetrafluoropropeno.
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
WO2009128973A3 (en) Methods for the production of silver nanowires
MY158251A (en) Method for the preparation of nalmefene hydrochloride
NZ595591A (en) Processes for the preparation of morphinane and morphinone compounds
TN2012000506A1 (en) Process for the preparation of pleuromutilins
WO2011004980A3 (ko) 트리사이클릭 유도체의 제조방법
SG2013049648A (en) Chlorination of carbohydrates and carbohydrate derivatives
WO2009063856A1 (ja) セルロースエーテル誘導体の製造方法
WO2012070747A3 (ko) 폴리유산과 고전도성 폴리유산 중합체의 제조방법 및 고전도성 폴리유산 중합체의 제조장치
NZ603653A (en) Processes for the preparation of dipyridamole
WO2011114210A3 (en) Processes for the preparation of linezolid
MX357865B (es) Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos.
NZ608028A (en) Improved method for preparing dipeptidyl peptidase-iv inhibitor and intermediate
GB201104203D0 (en) Chemical process
MX2012000431A (es) Procedimientos para 3-amino-5-oxo-4,5-dihidro-[1,2,4]triazinas sustituidas.
MX2012001675A (es) Procedimiento para preparar 2,4-dioxotetrahidrofuran-3-carboxilato s.
NZ589867A (en) Process for the synthesis of n-demethylated morphinane compounds
WO2011048612A3 (en) Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof
WO2008111521A1 (ja) ヨウ素化剤の製造方法、および芳香族ヨウ素化合物の製造方法
TW200626606A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond